Page 29 - MI-1-1
P. 29

Microbes & Immunity                                      RANTES/CCL5 and ezrin peptide RepG3 for long COVID



            53.  Steffens CM, Hope TJ. Localization of CD4 and CCR5 in      doi: 10.1186/s40880-019-0386-4
               living cells. J Virol. 2003;77(8):4985-4991.
                                                               64.  Lillard J, Boyaka P, Taub D, McGhee J. RANTES potentiates
               doi: 10.1128/JVI.77.8.4985–4991.2003               antigen-specific mucosal immune responses.  J  Immunol.
                                                                  2001;166(1):162-169.
            54.  Hammad MM, Kuang YQ, Yan R, Allen H, Dupre DJ. Na+/H+
               exchanger regulatory factor-1 is involved in chemokine receptor      doi: 10.4049/jimmunol.166.1.162
               homodimer CCR5 internalization and signal transduction   65.  Li N, Mirzakhani H, Kiefer A, et al. Regulated on activation,
               but does not affect CXCR4 homodimer or CXCR4-CCR5
               heterodimer. J Biol Chem. 2010;285:34653-34664.    normal T cell Expressed and secreted (RANTES) drives the
                                                                  resolution of allergic asthma. iScience. 2021;24:103163.
               doi: 10.1074/jbc.M110.106591
                                                                  doi: 10.1016/j.isci.2021.103163
            55.  Oppermann M. Chemokine receptor CCR5: Insights
               into  structure, function, and regulation.  Cell  Signal.   66.  Appay V, Dunbar PR, Cerundolo V, et al. RANTES activates
                                                                  antigen-specific cytotoxic T lymphocytes in a mitogen-like
               2004;16:1201-1210.
                                                                  manner through cell surface aggregation.  Int Immunol.
               doi: 10.1016/j.cellsig.2004.04.007                 2000;12(8):1173-1182.
            56.  Rieske P, Pongubala  JM. AKT  induces  transcriptional   67.  Appay  V,  Dunbar  PR,  Cerundolo  V,  McMichael  A,
               activity of PU.1 through phosphorylation-mediated   Czaplewski  L,  Rowland-Jones  S.  RANTES  activates
               modifications within its transactivation domain.  J  Biol   antigen-specific cytotoxic T lymphocytes in a mitogen-
               Chem. 2001;276(11):8460-8468.                      like manner through cell surface aggregation. Int Immunol.
               doi: 10.1074/jbc.M007482200                        2000;12(8):1173-1182.
            57.  Kanada S, Nishiyama C, Nakano N,  et al. Critical role of   68.  Li J, Tu Y, Wen J, Yao F, Wei W, Sun S. Role for ezrin in breast
               transcription  factor  PU.1  in the expression  of CD80  and   cancer cell chemotaxis to CCL5. Oncol Rep. 2010;24(4):965-971.
               CD86 on dendritic cells. Blood. 2011;117(7):2211-2222.     doi: 10.3892/or.2010.965
               doi: 10.1182/blood-2010-06-291898               69.  Zhang  Y, Zhai  Q,  Luo  Y,  Dorf  ME.  RANTES-mediated
            58.  Wen AY, Sakamoto KM, Miller LS. The role of the   chemokine transcription in astrocytes involves activation
               transcription factor CREB in immune function. J Immunol.   and translocation of p90 ribosomal S6 protein kinase (RSK).
               2010;185:6413-6419.                                J Biol Chem. 2002;277(21):19042-19048.
               doi: 10.4049/jimmunol.1001829                      doi: 10.1074/jbc.M112442200.
            59.  Amella CA, Sherry B, Shepp DH, Schmidtmayerova  H.   70.  Kim HY, Cha HJ, Kim HS. CCL5 upregulates IL-10 expression
               Macrophage  inflammatory  protein  1alpha  inhibits   and partially mediates the antihypertensive effects of IL-10
               postentry steps of human immunodeficiency virus type 1   in  the  vascular  smooth  muscle  cells  of  spontaneously
               infection via suppression of intracellular cyclic AMP. J Virol.   hypertensive rats. Hypertens Res. 2015;38:666-674.
               2005;79(9):5625-5631.                              doi: 10.1038/hr.2015.62
               doi: 10.1128/JVI.79.9.5625–5631.2005            71.  Nieto M, Navarro F, Perez-Villar JJ, et al. Roles of chemokines
            60.  Zhao J, Ma L, Wu YL, Wang P, Hu W, Pei G. Chemokine   and receptor polarization in NK-target cell interactions.
               receptor CCR5 functionally couples to inhibitory G proteins   J Immunol. 1998;161(7):3330-3339.
               and undergoes desensitization. J Cell Biochem. 1998;71:36-45.     doi: 10.4049/jimmunol.161.7.3330
               doi: 10.1002/(sici)1097-4644(19981001)71:1<36:aid-jcb4>3.0.co;2-2  72.  Bhat H, Zaun G, Hamdan TA, Lang J,  et  al. Arenavirus

            61.  Lorenzen E, Ceraudo E, Berchiche YA,  et al.  G  protein   induced CCL5 expression causes NK cell-mediated
               subtype-specific  signaling  bias  in  a  series  of  CCR5   melanoma regression. Front Immunol. 2020;11:1849.
               chemokine analogs. Sci Signal. 2018;11:eaao6152.     doi: 10.3389/fimmu.2020.01849
               doi: 10.1126/scisignal.aao6152                  73.  Casola A, Garofalo RP, Haeberle H,  et al. Multiple CIS
            62.  Pollok-Kopp B, Schwarze K, Baradari VK, Oppermann M.   regulatory elements control RANTES promoter activity in
               Analysis of ligand-stimulated CC chemokine receptor 5   alveolar epithelial cells infected with respiratory syncytial
               (CCR5) phosphorylation in intact cells using phosphosite-  virus. J Virol. 2001;5(14):6428-6439.
               specific antibodies. J Biol Chem. 2003;278(4):2190-2198.
                                                                  doi: 10.1128/JVI.75.14.6428–6439.2001
               doi: 10.1074/jbc.M209844200
                                                               74.  Genin P, Algarte M´, Roof P, Lin R, Hiscott J. Regulation of
            63.  Glorieux C, Huang P. Regulation of CD137 expression   RANTES chemokine gene expression requires cooperativity
               through K-Ras signaling in pancreatic cancer cells. Cancer   between NF-kB and IFN-regulatory factor transcription
               Commun (Lond). 2019;39:41.                         factors. J Immunol. 2000;164(10):5352-5361.


            Volume 1 Issue 1 (2024)                         23                               doi: 10.36922/mi.2474
   24   25   26   27   28   29   30   31   32   33   34